EMS Laboratory invests R $500 mi in medical prescription medications

The pharmaceutical manufacturer of generic EMS is investing R $500 million in its area of medications with medical prescription, to leverage in 20% the turnover of this segment in 2019, to R $2 billion. The resources will be directed to expand the sales force, promote the drive portfolio, marketing and launch of six new medications. In the apelonext to the medical class, EMS wants to increase the propagandists team to approximately 2000 professionals, from the current 1600. They are responsible for achieving no less than an average of 440,000 visits per month or about 22000 per day.